Ziltivekimab Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation (Novo Nordisk)

Protocol Name: ZEUS – A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

Sponsor: Novo Nordisk

Indication: Dual Diagnosis of Chronic Kidney Disease & Cardiovascular Disease

Primary Investigator: Ankit Mehta, MD

Location: Dallas Transplant Institute, 3604 Live Oak Street, Suite 100, Dallas, TX 75204

DETAILS >